Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-12

Clinical Trial Update: Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rosuvastatin/amlodipine vs atorvastatin/amlodipine in patients with dyslipidemia and hypertension; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atorvastatin/Amlodipine (atorvastatin/amlodipine)
  • Rosuvastatin/Amlodipine (rosuvastatin/amlodipine)

Snippet

Sponsor: Yuhan Corporation | Conditions: Dyslipidemias, Hypertension | Phase 4 | Status: COMPLETED